It is intriguing to speculate that stronger expression of IDH1 R132H, as seen in BT142, may predict tumor response in low grade glioma patients, but this hypothesis requires additional preclinical and/or clinical validation. This evidence concerns the gene IDH1 and central nervous system cancer.